Hangzhou Diagens Biotechnology Co., Ltd. (2526)
Market Closed
29 Sep, 08:00 AM
HKEX HKEX Primary 303. 20
HKD -32.2
-9.6005%
38.56B Market Cap
- P/E Ratio
- Div Yield
58,100 Volume
- Eps
335.4 HKD
Previous Close Want to track 2526 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Summary
2526 closed Tuesday lower at 303.2 HKD, a decrease of -9.6005% from Monday's close, completing a monthly decrease of -42.4668% or -223.8 HKD. Over the past 12 months, 2526 stock gained 38.4475%.
2526 is not paying dividends to its shareholders.
The stock of the company had never split.
The company's stock is traded on one exchange.
2526 Chart
Hangzhou Diagens Biotechnology Co., Ltd. (2526) FAQ
What is the stock price today?
The current price is 303.20 HKD.
On which exchange is it traded?
Hangzhou Diagens Biotechnology Co., Ltd. is listed on HKEX.
What is its stock symbol?
The ticker symbol is 2526.
Does it pay dividends? What is the current yield?
It does not pay dividends to its shareholders.
What is its market cap?
As of today, the market cap is 38.56B.
Has Hangzhou Diagens Biotechnology Co., Ltd. ever had a stock split?
No, there has never been a stock split.
Hangzhou Diagens Biotechnology Co., Ltd. Profile
| - Industry | - Sector | - CEO | HKEX Exchange | - ISIN |
| China Country | 174 Employees | - Last Dividend | - Last Split | - IPO Date |
Overview
Hangzhou Diagens Biotechnology Co., Ltd. is a prominent medical devices company that specializes in the development of advanced medical imaging products and services. With a diversified operational structure, the company is divided into several segments: Medical Imaging Software and Medical Devices, Technology Licensing, Analysis and Consulting Services, and Others. The company is situated in Hangzhou, China, and plays a crucial role in the medical equipment and technology sector, contributing significantly to advancements in diagnostics, particularly in genetic and cellular analysis for healthcare professionals in both clinical and research contexts.
Products and Services
- AI AutoVision: This innovative chromosome karyotype assisted diagnosis and analysis system provides intelligent karyotyping analysis. It is primarily utilized for applications in genetics and hematologic oncology, facilitating accurate diagnosis and improved patient outcomes in these sensitive fields.
- MetaSight: An automatic cell microscopic image scanning system, MetaSight automates the processes of scanning, positioning, image acquisition, and output for chromosome or cell samples. It serves cytogenetics applications, including genetics health, radiation health, and hemato-oncology, thereby significantly enhancing workflow efficiency in diagnostic laboratories.
- KayoFlow: This product is an automatic cell harvester designed for the pre-analytical processing of various sample types such as peripheral blood, amniotic fluid, and bone marrow. KayoFlow streamlines the harvesting process, contributing to improved reliability and efficiency in testing and analysis.
- Technology Licensing: Hangzhou Diagens also offers technology licensing services, providing valuable access to proprietary technologies and innovations in medical imaging and diagnostics.
- Analysis and Consulting Services: The company delivers specialized consultations and analytical services to aid healthcare professionals and researchers in navigating complex diagnostic challenges and implementing new technologies effectively.
Contact Information
Address: Room 101
Phone: 86 40 0068 0888
Website: https://www.diagens.com
2026 © Marketlog. All Rights Reserved.
